Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication

Lisa F P Ng1, Marieta Chan, Soh-Ha Chan

  • 1Genome Institute of Singapore, Singapore.

Plos Medicine
|July 22, 2005
PubMed
Abstract

Insights

Hepatitis B virus (HBV) replication is influenced by the host factor hnRNP K. Modulating hnRNP K levels can control HBV viral load in carriers, offering a new therapeutic target.

Area of Science:

  • Virology
  • Molecular Biology
  • Hepatology

Background:

  • Hepatitis B virus (HBV) infection can lead to severe liver diseases like cirrhosis and cancer.
  • Controlling HBV replication in chronic carriers is crucial for disease management.
  • Identifying host factors influencing HBV replication is essential for developing new therapies.

Purpose of the Study:

  • To identify host factors significantly affecting Hepatitis B virus replication efficiency.
  • To investigate the role of specific HBV genetic variants in viral load.

Main Methods:

  • Analysis of serum viral load and HBV genomes in hepatitis B carriers.
  • Identification of host DNA-binding proteins interacting with HBV regulatory regions using affinity probes.
  • Cell transfection studies to assess the effect of hnRNP K modulation (overexpression and gene silencing) on HBV replication.

Main Results:

  • A significant association was found between high serum viral load and an HBV Enhancer II sequence variant (position 1752).
  • The host DNA-binding protein hnRNP K was identified as a modulator of HBV replication.
  • Overexpression of hnRNP K increased HBV replication, while its silencing significantly reduced HBV viral load.

Conclusions:

  • hnRNP K plays a role in HBV replication beyond its known cellular functions.
  • hnRNP K represents a potential novel target for pharmacological interventions against HBV infection.

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
61.4K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73